Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

CHANGZHOU PHARM

  • FDA Approval
  • May 20, 2025, 08:42 UTC
  • 7

FDA approve RIVAROXABAN

Comment Full text

ASCENT PHARMS INC

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 13

FDA approve RIVAROXABAN

Comment Full text

GENENTECH

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 5

FDA approve ADO-TRASTUZUMAB EMTANSINE

Comment Full text

GUANGDONG SUNHO

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 6

FDA approve DOCETAXEL

Comment Full text

NAVINTA LLC

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 6

FDA approve MARAVIROC

Comment Full text

ENCUBE

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 7

FDA approve MUPIROCIN

Comment Full text

PIRAMAL

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 7

FDA approve AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL

Comment Full text

PADAGIS US

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 8

FDA approve HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE

Comment Full text

CAPLIN

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 8

FDA approve HALOPERIDOL DECANOATE

Comment Full text

AUROBINDO PHARMA

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 10

FDA approve DABIGATRAN ETEXILATE MESYLATE

Comment Full text
  • Previous
  • 11
  • 12
  • 13
  • 14
  • 15
  • Next

Search

News categories

  • Technical Exchange News(9309)
  • Event(407)
  • SEC News(150123)
  • FDA Approval(8569)
  • Company Report(721)
  • Business News(103322)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin